Categories: COVID-19

WHO adds ‘lifesaving’ drugs for severely ill COVID-19 patients

Spread the news

The World Health Organization (WHO) has added aid in the treatment of Covid19 calling it “lifesaving”-interleukin-6 receptor blockers– only the second drugs to be recommended as effective against the disease – because the pandemic continues to accelerate across the globe.

The WHO said after observing the medicines worked particularly well when used along with corticosteroids, which were recommended in September 2020. These drugs offer hope for patients and families who are suffering from the devastating impact of severe and important COVID-19.

Patients with severe cases of COVID-19 often suffer from an overreaction of the system and therefore the interleukin-6 blocking drugs – tocilizumab and sarilumab – act to suppress the overreaction.

Data source: World Health Organization and news agencies

TOA Correspondent

Recent Posts

The top Nigerian who hated his own voice

Nigeria’s leading music figure and vocalist, Cobhams Asuquo, known for his singing and production said…

3 years ago

South African court halts Amazon HQ project

Following a mixed reaction from the South African community representatives, Khoi and San, the Cape…

3 years ago

How Digitalization in African Rail Transportation Is Enhancing Safety?

Mitigating the process and service barriers in African rail transportation, the digital disruption has transformed…

3 years ago

Tunisian leader to allow public views on reforms

Kais Saied, the Tunisian president has said in his speech that he will allow the…

3 years ago

The power of Niacinamide in the trending African skincare market

You know the credibility of an ingredient when it’s plastered all over bottles and jars…

3 years ago

Mozambique death toll from Cyclone Gombe rises to 48

Cyclone Gombe that flooded large areas of central and northern Mozambique is consistently leading to…

3 years ago

This website uses cookies.